• 동국한의학연구소논문집
• /
• 제2권1호
• /
• pp.107-125
• /
• 1993

This study was performed to investigate the effects of Gwaluzisiltang and Gwaluzisiltanggami on the intravascular coagulation. The experimental group divided two groups : one group was the intravascular coagulation induced by endotoxin in rats, another group was the formation of paw edema by contusion in rats, and then these rats were treated with liquid extract of Gwaluzisiltang(Sample I) and Gwaluzisiltanggami(Sample II), which were administered orally. Then the numbers of platelets, concentration of fibrinogen, Prothrombin time and FDP(fibrin-fibrinogen degradation Products)were measured. The results were as follows : 1. The effects of the Intravascular coagulation 1) Platelet was increased significantly in the sample I compared with control group. 2) Fibrinogen was increased significantly in the sample I compared with control group. 3) Prothrombin time was shortened significantly in the sample I and more shortened in the sample II compared with control group. 4) FDP was decreased significantly in the sample I and more decreased in the samplem II compared with control group. 2. The effect of the formation of paw edema by contusion in rats. 1) The rate of paw edem was decreased significantly after five hours in the sample I 2) Platelet was increased significantly in the sample I compared with control group. 3) Fibrinogen was decreased in the sample I and sample II compared with control group, but it is not significant 4) Prothrombin time was shortened significantly in the sample II compared with control group. According to the above results, it is considered that the Gwaluzisiltang and Gwaluzisiltanggami seem to be applicable disease related to thrombosis, because they obtained significant effects on the experimental method which are based on the oriental medical theory-the principle of phlegm and blood stasis have the same source and disease (痰瘀同源, 痰瘀同病).

• 대한한방내과학회지
• /
• 제22권1호
• /
• pp.39-44
• /
• 2001

Objective : This experimental study was carried out to investigate the effects of Persicae Semen(PS) and Caesalpiniae Lignum(CL) on the intravascular coagulation which is considered as thrombosis. Methods : Rats were pretreated orally with PS and CL extracts(PS: 8.45mg/100g, CL: 4.4mg/100g), and 1 hour later, to induce thrombosis, were given an endotoxin(0.01mg/100g) injection into the caudal vein. After 4hours we collected blood by cardiac puncture and measured the platelet count, the prothrombin time, the level of fibrinogen and the FDP(fibrinogen degradation product). Results : PS and CL supressed the decrease of the Platelet count and the prolongation of prothrombin time. In these factors, both groups showed significant effect. Both groups supressed the decrease of the fibrinogen level and the increase of the FDP level. But, only the PS group showed a significant effect on the fibrinogen level, and only the Cle CL group showed a significant effect on FDP level. Conclusions : PS had significant effects on the platelet count, the prothrombin time, and the FDP level. CL had significant effects on the platelet count, the prothrombin time, and the fibrinogen level. Therefore, PerSicae Semen and Caesalpiniae Lignum seem to be applicable to treating the diseases related to thrombosis.

• 대한한방내과학회지
• /
• 제28권3호
• /
• pp.464-472
• /
• 2007

Objectives : Nowadays the combined use of oriental herbal medicines and western biomedical medicines has been prevalent but controversial. Warfarin has been much reported to interact with some herbal medicines so that it influences prothrombin time(PT) & international normalized ratio(INR). This study was aimed to examine how much warfarin interacts with herbal medicines during treatment of stroke patients Methods : This was a retrospective case control study of 53 patients whowere treated with concomitant treatment of herbal medicines & warfarin. They were within normal limit in liver function, renal function, hematocrit, hemoglobin, and platelet count at first admission lab. We classified them into 2 classes: study group (taking herbal medicines including Panax ginseng, Angelica sinensis, Zingiber officinale, Salvia miltiorrhiza that were reported to interact with warfarin to impact PT (INR) and control group (taking other herbal medicines). We followed up PT (INR) at 5-10 days interval with AST, ALT, BUN, creatinine, hematocrit, hemoglobin, and platelet count. Results : AST, BUN, creatinine, hemoglobin, hematocrit, and platelet count were not changed significantly between first and final tests during the admission period. Only ALT decreased significantly in the control group. Neither baseline nor peak PT (INR) was significantly different between the groups. However, only warfarin dose was significantly correlated with PT and INR (r=0.810, r=0.798, p<0.01). Conclusions : It was concluded that PT(INR) was not influenced with herbal medicines and warfarin but by far dependent on warfarin dose in stroke patients restricted with normal liver function, renal function, and hematocrit, hemoglobin, and platelet count. Further prospective study is needed on larger samples to conclude that the combined therapy of herbal medicines and warfarin is safe.

• 동국한의학연구소논문집
• /
• 제2권1호
• /
• pp.19-54
• /
• 1993

To see both $Sh{\grave{u}}nq{\grave{i}}daot{\acute{a}}nt{\bar{a}}ng$(dissipate phlegm and promote vital energy circulation) and $Hu{\grave{a}}y{\bar{u}}t{\bar{a}}ng$(blood circulation and disperse blood stasis) influencing on thrombosis, contusion-hyperemia, and hyperlipidemia, at first we measured the density of FDP, the quantity of fibrinogen, prothrombin time, and the number of platelet of rat taken thrombosis by endotoxin. Secondly we measured the increase-rate of "paw swelling", the number of platelet, the quantity of fibrinogen, and prothrombin time of rat taken contusion-hyperemia. And then we measured the quantity of total cholesterol in serum and of H.D.L-cholesterol and of triglyceride and of phospholipid and of ${\beta}-lipoprotein$, its weight, and the variation of the quantity of electrolyte of rat taken hyperlipidemia by the oral-injection of choleserol. As a result, we can conclude as follows : 1. Out of the test of thrombosis, we can recognize not only the noticeable increae of the number of platelet and the quantity of fibrinogen, but also the noticeable decrease of prothrombin time and the density of FDP in case of $Sh{\grave{u}}nq{\grave{i}}daot{\acute{a}}nt{\bar{a}}ng$-injected rat and $Hu{\grave{a}}y{\bar{u}}t{\bar{a}}ng$-injected rat. 2. Out of the test of contusion-hyperemia, we can recognize not only the noticeable increase of the number of platelet and the quantity of fibrinogen, but also the noticeable decrease of prothrombin time and "increase-rate of paw swelling" in case of $Sh{\grave{u}}nq{\grave{i}}daot{\acute{a}}nt{\bar{a}}ng$-injected rat and $Hu{\grave{a}}y{\bar{u}}t{\bar{a}}ng$-injected rat. 3. Out of the test of hyperlipidemia, at first we can recognize that test rat's weight increased as close as that of normal rat. And we can recognize the noticeable decrease of the triglyceride and phospholipid and ${\beta}-lipoprotein$." Also, in case of the variation of electrolyte we can recognize the decrease of calcium and potassium in $Sh{\grave{u}}nq{\grave{i}}daot{\acute{a}}nt{\bar{a}}ng$-injected rat, and of sodium and magnesium in $Hu{\grave{a}}y{\bar{u}}t{\bar{a}}ng$-injected rat. Thus, as the above-mentioned, in covering thrombosis, contusion-hypermia, and hyperlipidemia, the effect of $Sh{\grave{u}}nq{\grave{i}}daot{\acute{a}}nt{\bar{a}}ng$ and $Hu{\grave{a}}y{\bar{u}}t{\bar{a}}ng$ can be recognized. Granting that $Hu{\grave{a}}y{\bar{u}}t{\bar{a}}ng$ reveals its effectiveness in thrombosis and contusion-hyperemia, and $Sh{\grave{u}}nq{\grave{i}}daot{\acute{a}}nt{\bar{a}}ng$ in hyperlipidemia, it can be inferred that contusion-hyperemia is like "model of blood stasis form" as thrombosis and hyperlipidemia "phlegm-retention diseases form", and both phlegm-retention and blood stasis have correlation each other.

• 한방안이비인후피부과학회지
• /
• 제15권1호
• /
• pp.63-75
• /
• 2002

Based upon our laboratory experiments of Yongdamsagantang subtracted Bupleuri Radix and Yongdamsagantang subtracted Bupleuri Radix added Biotac Cacumen, Imperatae Rhizoma, Typhae Pollen on male rats to examine the medicines' hemostatic effect, we draw conclusions as follows: 1. Compared to the control group, Yongdamsagantang subtracted Bupleuri Radix and Yongdamsagantang subtracted Bupleuri Radix added Biotae Cacumen, Imperatae Rhizoma, Typhae Pollen increased the number of platelet counts meaningfully. 2. Compared to the control group, Yongdamsagantang subtracted Bupleuri Radix and Yongdamsagantang subtracted Bupleuri Radix added Biotae Cacumen, Imperatae Rhizoma, Typhae Pollen suppressed prothrombin time without any meaning. 3. Compared to the control group, Yongdamsagantang subtracted Bupleuri Radix and Yongdamsagantang subtracted Bupleuri Radix added Biotae Cacumen, Imperatae Rhizoma, Typhae Pollen, all of these medicines elevated the fibrinogen level, but only Yongdamsagantang subtracte Bupleuri Radix is recognized to raise the fibrinogen level meaningfully. 4. Compared to the control group, Yongdamsagantang subtracted Bupleuri Radix and Yongdamsagantang subtracted Bupleuri Radix added Biotae Cacumen. Imperatae Rhizoma, Typhae Pollen repressed partial thromboplastin time meaningfully. In conclusion, Yongdamsagantang subtracted Bupleuri Radix and Yongdamsagantang subtracted Bupleuri Radix added Biotae Cacumen, Imperatae Rhizoma, Typhae Pollen can be used for stopping blood effectively in terms of platelet count increase, prothrombin time control, fibrinogen level rise, and partial thromboplastin time suppression.

• 한방안이비인후피부과학회지
• /
• 제16권1호
• /
• pp.63-76
• /
• 2003

This Experiment was conducted to investigate the hemostatic effects of Guipitang and Guipitangjiaweifang. For this purpose, the effects of the crude extracts on the platelet count. prothrombin time, fibrinogen level and partial prothromboplastin time were estimated. The rats were divided into normal group, control group and experimental group. Control group was administrated normal saline and experimental group was divided into Sample 1 (Guipitang) and Sample 2 (Guipitangjiaweifang). The results obtained were as follows : 1. The platelet count was significantly increased in both of two samples as compared with the control group. 2. The prothrombin time was significantly shortened in case of Sample 2. however there were no significant changes in case of Sample 1 as compared with the control group. 3. The fibrinogen level was significantly increased in case of Sample 1. however there were no meaningful changes in case of Sample 2 as compared with the control group. 4. The partial prothromboplastin time was significantly shortened in both of two samples as compared with the control group. According to above results. it is supposed that Guipitang and Guipitangjiaweifang have the hemostatic effects in experimental animals.

• 대한의생명과학회지
• /
• 제16권4호
• /
• pp.377-380
• /
• 2010

In this study, we investigated the effect of egg yolk lipids (EYL) on collagen ($10\;{\mu}g/ml$)-stimulated platelet aggregation in vivo. Dietary EYL significantly inhibited collagen-induced platelet aggregation, in addition, increased the formation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), intracellular $Ca^{2+}$-antagonist as aggregation-inhibiting molecules, in collagen-stimulated platelets. These results suggest that EYL inhibits the collagen-induced platelet aggregation by up-regulating the cAMP and cGMP production. On the other hands, prothrombin time (PT) on extrinsic pathway of blood coagulation was potently prolonged by dietary EYL in vivo. These findings suggest that EYL prolongs the internal time between the conversion of fibrinogen to fibrin. Accordingly, our data demonstrate that EYL may be a crucial tool for a negative regulator during platelet activation and blood coagulation on thrombotic diseases.

• 혜화의학회지
• /
• 제4권2호
• /
• pp.91-103
• /
• 1996

This study was performed to prove the clinical effects of Kyejibokryoung hwan(KBH), Jeodangtang(JDT), Kyejibokryounghwan & Jeo-dangtang(KJT) by way of experimental methods. The intravascular coagulation was induced by injection of endotoxin into the caudal vein of rats. And liquid extracts of Kyejibokryounghwan, Jeodangtang, Kyejibokryounghwan & Jeodang- tang were administerd orally to the rats. Then the number of platelets, concentration of fibrinogen, FDP(fibrin-fibrinogen degradation products), prothrombin time and PTT(partial thromboplastin time) were measured. The results were obtained as follows ; 1. The number of platelets was significantly increased in KBH and KJT-treated groups in comparison with the control group. 2. Fibrinogen was significantly increased in all sample groups as compared with the control group. 3. FDP was insignificantly decreased in all sample groups but have not significant. 4. Prothrombin time was significantly shortened in JDT and KJT-treated groups as compared with the control group. 5. PTT was significantly shortened in only KJT -treated groups as compared with the control group. From the above results, it was concluded that Kyejibokryounghwan, Jeodang tang, Kyejibokryounghwan & Jeodangtang can be applied effectively in the disease of thrombosis.

• 생명과학회지
• /
• 제20권6호
• /
• pp.922-928
• /
• 2010

한방 생약재로부터 안전하면서도 신규의 항혈전제를 개발하기 위해, 현재 국내에서 유통되고 있는 국내 및 국외산 한방 생약재 33종을 대상으로 40종의 에탄올 추출물을 조제하고, 이들의 thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (aPTT)을 평가하였다. 생약재중 중국산은 28종으로 대부분이 국외산이었으며, 부위별로는 종자 및 뿌리 부위가 19종을 차지하였다. 평균 수분함량은 $6.85{\pm}2.26%$, 평균 추출율은 $5.27{\pm}4.25%$를 나타내었다. 조제된 시료의 TT평가 결과, 사인(중국), 고본, 팔각향, 계지, 당삼, 계혈등, 행인, 오배자, 괄루근 및 포황에서 우수한 트롬빈 저해활성을 확인하였으며, 다양한 농도에서 평가 결과 계혈등, 행인, 팔각향, 계지, 오배자 추출물 순으로 트롬빈 저해능이 강력함을 확인하였다. PT 평가 결과 오배자, 계혈등, 행인에서, aPTT 평가결과 오배자 및 계혈등에서 우수한 항혈전능을 확인하였다. 한편 추출물의 인간적혈구 용혈활성을 평가한 결과, 계혈등, 팔각향, 계지, 오배자 추출물은 $500\;{\mu}g/ml$ 농도에서도 용혈활성이 없음을 확인하여 이들 4종을 최종 선정하였다. 본 연구결과는 이미 대량생산이 확립된 한방생약제로부터 우수한 항혈전제 개발이 가능함을 제시하고 있으며, 트롬빈 및 혈장 응고 인자에 대한 특이 저해제 개발이 가능함을 제시하고 있다.

• Tuberculosis and Respiratory Diseases
• /
• 제47권6호
• /
• pp.768-774
• /
• 1999

연구배경: 리팜핀(rifampin)은 간의 시토크폼 P-450 효소를 유도하여 이 효소에 의해서 대사되는 와파린(warfarin)의 항응고 효과를 감소시킨다. 이와 같은 리팜핀과 와파린의 약제 상호작용에 대해서 건강한 지원자가 아닌 환자를 대상으로 아래의 문제를 해결하고자 본 연구를 수행하였다. 첫째 와파린을 투여하는 환자에게 리팜핀을 추가할 경우 리팜핀 투여 전, 중, 후에 항응고 효과를 적절히 유지하기 위한 와파린 용량, 둘째 리팜핀 추가 후 적절한 와파린 증량 방법(시간 계획), 셋째 와파린과 리팜핀을 함께 투여하는 경우 합병증등을 살펴 보았다. 방 법: 1995년 1월부터 1999년 8월까지 부천 세종병원에 입원한 환자 중 와파린과 리팜핀을 동시에 투여한 환자를 찾아서 질병 기록을 후향적으로 확인하였다. 리팜핀 투여 전, 중, 후의 와파린 필요량을 '적절한 항응고' 상태를 유지한 환자를 대상으로 조사하였다. 그리고, 리팜핀 추가 시 와파린 증량 방법(시간 계획)을 리팜핀 투여 후 prothrombin time 이 INR 1.1이하로 떨어지는데 걸리는 시간을 측정하여 간접적으로 평가하였다. 마지막으로 리팜핀과 와파린 동시 투여시 합병증을 조사하였다. 결 과: 라팜핀과 와파린을 동시에 투여한 환자는 모두 12명이었고 이 중 리팜핀 투여 기간 중에 '적절한 항응고' 상태를 유지한 환자는 6명이었다. 이 6명환자의 와파린 용량은 리팜핀 투여 중에 증가하여(p<0.05) 리팜핀 투여 전과 비교하여 $2.4{\pm}0.6$(평균${\pm}$표준편차) 배이었다. 그라고, 리팜핀을 중지한 후의 와파린 용량은 다시 감소하여 거의 리팜핀 사용 전의 용량으로 돌아갔다. 리팜핀 투여 후 prothrombin time이 INR 1.1이하로 떨어지는데 걸리는 시간은 $5.8{\pm}2.9$ (평균$\pm$표준편차) 일이었다. 2명이 리팜핀과 와파린 동시 투약과 관련되어 합병증이 발생하였다. 한 명은 낮은 항응고 상태 때문에 뇌색전증이 발생하였고, 다른 한명은 높은 항응고 상태 때문에 뇌출혈이 발생하여 사망하였다. 결 론: 와파린과 리팜핀을 동시에 투약하는 경우, 적절한 항응고 효과를 유지하기 위해서 리팜핀 추가 시 와파린을 약 1주에 걸쳐서 단계적으로 약 2배 증량하고 리팜핀 중단 시 리팜핀 투여 전의 와파린 용량으로 감량하는 방법을 시도해 불 수 있겠고, 이를 향후 전향적 연구를 통해서 확인하는 것이 필요하다. 또한, 리팜핀을 추가하거나 중단할 때 합병증이 발생하지 않도록 항응고 상태를 자주 감시하는 것이 필요하리라 생각된다.